SKI Market

Indian Indices

Sensex

83,576.24 -604.72
( -0.72%)

Global Indices

Nasdaq

49,277.91 260.82
(0.53%)

Dow Jones

6,942.18 0.25
(0.00%)

Hang Seng

51,918.01 800.75
(1.57%)

Nikkei 225

10,051.56 3.35
(0.03%)

Forex

USD-INR

89.93 -0.23
(-0.25%)

EUR-INR

105.10 -0.46
(-0.44%)

GBP-INR

121.29 -0.65
(-0.53%)

JPY-INR

0.57 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

22.7

117983.06

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.1

Back

radhagobind commercial ltd

Ajanta Soya standalone net profit declines 33.46% in the September 2025 quarter

Nov 15,2025

Net profit of Ajanta Soya declined 33.46% to Rs 5.27 crore in the quarter ended September 2025 as against Rs 7.92 crore during the previous quarter ended September 2024. Sales rose 14.16% to Rs 346.93 crore in the quarter ended September 2025 as against Rs 303.89 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	346.93	303.89	14
OPM %	2.29	3.62	-
PBDT	8.32	11.19	-26
PBT	7.57	10.48	-28
NP	5.27	7.92	-33

83,576.24 -604.72 ( -0.72%)

49,277.91 260.82 (0.53%)

6,942.18 0.25 (0.00%)

51,918.01 800.75 (1.57%)

10,051.56 3.35 (0.03%)

89.93 -0.23 (-0.25%)

105.10 -0.46 (-0.44%)

121.29 -0.65 (-0.53%)

0.57 0.00 (-0.31%)